|
Market Closed -
Nasdaq
16:00:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 18.25 USD | +5.13% |
|
-3.18% | - |
| 11-03 | MiniMed Names David Segal as Chief Medical Officer | MT |
| 10-16 | MiniMed Appoints Amy Bricker to Board Following Medtronic Separation | MT |
| Market Cap | 4.88B 4.4B 4.06B 3.68B 6.96B 458B 7.14B 48.67B 19.41B 245B 18.33B 17.94B 779B | P/E 2027 * |
27.7x | P/E 2028 * | 24x |
|---|---|---|---|---|---|
| Enterprise Value | 4.61B 4.16B 3.84B 3.47B 6.57B 432B 6.75B 45.99B 18.34B 232B 17.32B 16.95B 737B | EV / Sales 2027 * |
1.34x | EV / Sales 2028 * | 1.15x |
| Free-Float |
99.88% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MMED | Delayed | |
CBOE
| MMED | Real-time | |
|
Tradegate
| B8S | Real-time | |
|
Boerse Muenchen
| B8S | Real-time | |
|
Deutsche Boerse AG
| B8S | Delayed | |
|
Börse Stuttgart
| B8S | Delayed |
Last Transcript: MiniMed Group, Inc.
| 1 day | +5.13% | ||
| 1 week | -3.18% | ||
| Current month | -0.16% | ||
| 1 month | -7.41% | ||
| 3 months | -6.41% | ||
| 6 months | +57.74% |
| 1 week | 16.66 |  | 19.63 |
| 1 month | 16.56 | | 19.92 |
| Current year | 10.65 | | 24.43 |
| 1 year | 10.65 | | 24.43 |
| 3 years | 10.65 | | 24.43 |
| 5 years | 10.65 | | 24.43 |
| 10 years | 10.65 | | 24.43 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/28/26 | Tax | Chief Technology Officer | -449 | 0.0002% | ||
| 10/15/26 | Free | Director | 11,877 | 0.0042% | ||
| 10/15/26 | Free | Director | 3,374 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.13% | -3.18% | - | - | 4.88B | |
| -1.06% | -0.10% | -13.19% | +16.30% | 191B | |
| +0.02% | +2.76% | +9.66% | +43.76% | 124B | |
| -1.70% | +2.65% | -10.21% | +16.51% | 123B | |
| -2.69% | -0.92% | -41.45% | +4.37% | 96.14B | |
| +0.34% | +2.75% | -4.05% | +77.09% | 66.54B | |
| +0.90% | +8.25% | +18.10% | -8.58% | 57.91B | |
| +0.85% | +4.55% | -0.99% | +63.88% | 54.89B | |
| +1.47% | -3.69% | -4.56% | +55.85% | 49.1B | |
| -3.88% | -0.60% | -0.03% | -8.41% | 36.19B | |
| Average | +0.19% | +1.37% | -5.19% | +28.97% | 80B | |
| Weighted average by Cap. | -0.14% | +2.31% | -7.58% | +27.00% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 3.44B 3.1B 2.86B 2.59B 4.89B 322B 5.02B 34.23B 13.65B 173B 12.89B 12.62B 548B | 3.73B 3.36B 3.1B 2.81B 5.31B 349B 5.45B 37.15B 14.81B 187B 13.99B 13.69B 595B |
| Net income | 186M 167M 155M 140M 265M 17.41B 272M 1.85B 738M 9.33B 697M 682M 29.65B | 239M 216M 199M 180M 341M 22.41B 350M 2.38B 950M 12.01B 898M 878M 38.17B |
| Net Debt | -269M -243M -224M -203M -384M -25.23B -394M -2.68B -1.07B -13.53B -1.01B -989M -42.98B | -583M -526M -485M -439M -831M -54.66B -853M -5.81B -2.32B -29.31B -2.19B -2.14B -93.12B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | US$18.25 | +5.13% | 5,553,668 |
| 26-11-10 | US$17.36 | -2.91% | 4,453,316 |
| 26-11-09 | US$17.88 | +7.00% | 6,196,579 |
| 26-11-06 | US$16.71 | -7.96% | 7,479,451 |
| 26-11-05 | US$18.16 | -5.88% | 10,043,560 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MMED Stock
Select your edition
All financial news and data tailored to specific country editions
